The Driver of Extreme Human-Specific Olduvai Repeat Expansion Remains Highly Active in the Human

Total Page:16

File Type:pdf, Size:1020Kb

The Driver of Extreme Human-Specific Olduvai Repeat Expansion Remains Highly Active in the Human Genetics: Early Online, published on November 21, 2019 as 10.1534/genetics.119.302782 1 The Driver of Extreme Human-Specific Olduvai Repeat Expansion Remains Highly Active in the Human 2 Genome 3 Ilea E. Heft,1,* Yulia Mostovoy,2,* Michal Levy-Sakin,2 Walfred Ma,2 Aaron J. Stevens,3 Steven 4 Pastor,4 Jennifer McCaffrey,4 Dario Boffelli,5 David I. Martin,5 Ming Xiao,4 Martin A. Kennedy,3 5 Pui-Yan Kwok,2,6,7 and James M. Sikela1 6 7 1Department of Biochemistry and Molecular Genetics, and Human Medical Genetics and 8 Genomics Program, University of Colorado School of Medicine, Aurora CO 80045 9 2Cardiovascular Research Institute, 6Department of Dermatology, and 7Institute for Human 10 Genetics, University of California, San Francisco, San Francisco, CA, USA 11 3Department of Pathology, University of Otago, Christchurch, New Zealand 8140 12 4School of Biomedical Engineering, Drexel University, Philadelphia, PA 19104 13 5Children's Hospital Oakland Research Institute, Oakland, CA, 94609 14 15 Corresponding author: James M. Sikela: [email protected] 16 *Ilea E. Heft and Yulia Mostovoy contributed equally to this article. 17 1 Copyright 2019. 18 Abstract 19 Sequences encoding Olduvai protein domains (formerly DUF1220) show the greatest 20 human lineage-specific increase in copy number of any coding region in the genome and have 21 been associated, in a dosage-dependent manner, with brain size, cognitive aptitude, autism, 22 and schizophrenia. Tandem intragenic duplications of a three-domain block, termed the Olduvai 23 triplet, in four NBPF genes in the chromosomal 1q21.1-.2 region are primarily responsible for 24 the striking human-specific copy number increase. Interestingly, most of the Olduvai triplets are 25 adjacent to, and transcriptionally co-regulated with, three human-specific NOTCH2NL genes 26 that have been shown to promote cortical neurogenesis. Until now, the underlying genomic 27 events that drove the Olduvai hyper-amplification in humans have remained unexplained. Here, 28 we show that the presence or absence of an alternative first exon of the Olduvai triplet 29 perfectly discriminates between amplified (58/58) and unamplified (0/12) triplets. We provide 30 sequence and breakpoint analyses that suggest the alternative exon was produced by an NAHR- 31 based mechanism involving the duplicative transposition of an existing Olduvai exon found in 32 the CON3 domain that typically occurs at the carboxy end of NBPF genes. We also provide 33 suggestive in vitro evidence that the alternative exon may promote instability through a 34 putative G-quadraplex-based (pG4) mechanism. Lastly, we use single-molecule optical mapping 35 to characterize the intragenic structural variation observed in NBPF genes in 154 unrelated 36 individuals and 52 related individuals from 16 families and show that the presence of pG4- 37 containing Olduvai triplets is strongly correlated with high levels of Olduvai copy number 38 variation. These results suggest that the same driver of genomic instability that allowed the 2 39 evolutionarily recent, rapid, and extreme human-specific Olduvai expansion remains highly 40 active in the human genome. 41 Introduction 42 Sequences encoding Olduvai protein domains (formerly DUF1220) (Sikela and van Roy 43 2018) have undergone a human-specific hyper-amplification that represents the largest human- 44 specific increase in copy number of any coding region in the genome (Popesco et al. 2006; 45 O’Bleness et al. 2012). The current human reference genome [hg38] is reported to contain 302 46 haploid copies (Zimmer and Montgomery 2015), approximately 165 of which have been added 47 to the human genome since the Homo/Pan split (O’Bleness et al. 2012). Olduvai sequences are 48 found almost entirely within the NBPF gene family (Vandepoele et al. 2005) and have 49 undergone exceptional amplification exclusively within the primate order, with copy numbers 50 generally decreasing with increasing phylogenetic distance from humans: humans have ~300 51 copies, great apes 97-138, monkeys 48-75, and non-primate mammals 1-8 (Popesco et al. 2006; 52 O’Bleness et al. 2012; Zimmer and Montgomery 2015). 53 Olduvai copy number increase has been implicated in the evolutionary expansion of the 54 human brain, showing a linear association with brain size, neuron number, and several other 55 brain-size-related phenotypes among primate species (Dumas and Sikela 2009; Dumas et al. 56 2012; Keeney et al. 2014, 2015; Zimmer and Montgomery 2015). Among humans, Olduvai copy 57 number (total or subtype specific) has been linked, in a dosage-dependent manner, to brain 58 size, gray matter volume, and cognitive aptitude in healthy populations (Dumas et al. 2012; 59 Davis et al. 2015b), as well as with brain size pathologies (microcephaly/macrocephaly) (Dumas 3 60 et al. 2012). Increasing Olduvai copy number has also been linearly associated with increasing 61 severity of autism symptoms (Davis et al. 2014, 2015a, 2019), as well as increasing severity of 62 negative schizophrenia symptoms, which are phenotypically similar to the social deficits 63 associated with autism (Searles Quick et al. 2015). Conversely, decreasing copy number shows a 64 linear relationship with the severity of positive symptoms of schizophrenia (e.g., hallucinations, 65 delusions). Lending further support for a role in these disorders, 1q21.1-associated duplications 66 and deletions that encompass many Olduvai copies are among the most common structural 67 variations (SVs) associated with autism and schizophrenia, respectively (Brunetti-Pierri et al. 68 2008; Mefford et al. 2008; International Schizophrenia Consortium et al. 2009). Taken together, 69 these findings suggest that variation in Olduvai copy number can produce both beneficial (e.g., 70 increased brain size and cognitive function) and deleterious brain-related phenotypic outcomes 71 (Dumas and Sikela 2009). Such a duality in function fits well with models that propose that the 72 key genes that drove human brain evolution are also significant contributors to autism and 73 schizophrenia (Crow 1995; Burns 2007; Dumas and Sikela 2009; Sikela and Searles Quick 2018). 74 Finally, recent studies have shown that most human-specific Olduvai copies are encoded by 75 four NBPF genes on 1q21.1-2, three of which are adjacent to and co-regulated with three 76 human-specific NOTCH2NL genes (Fiddes et al. 2019). The three NOTCH2NL genes have been 77 shown to promote cortical neurogenesis (Fiddes et al. 2018; Suzuki et al. 2018), suggesting that 78 the human-specific Olduvai expansions and their adjacent NOTCH2NL partners may work in a 79 coordinated, complementary manner to drive human brain expansion in a dosage-related 80 fashion (Fiddes et al. 2019). 81 Olduvai domains are on average 65 amino acids in length (ranging from 61 to 74) (Finn 4 82 et al. 2014) and are encoded within a small exon and large exon doublet (Popesco et al. 2006). 83 The domains have been subdivided into 6 primary subtypes based on sequence similarity: 84 Conserved 1-3 (CON1-3) and Human Lineage Specific 1-3 (HLS1-3) (O’Bleness et al. 2012). 85 Sequences encoding the various subtypes are almost always found in the same order within 86 NBPF genes: one or more CON1 domains; a single CON2 domain; one or more instances of a 87 triplet composed of HLS1, HLS2, and HLS3 domains; and a single CON3 domain at the carboxy 88 end. A significant majority (114 copies) of the human-specific copies have been generated by 89 intragenic domain amplification (i.e., increases in the number of tandemly arranged copies) 90 primarily involving 4 of the 24 human NBPF genes (O’Bleness et al. 2012). These tandem 91 expansions are predominantly organized as contiguous three domain blocks, named Olduvai 92 triplets, each of which is approximately 4.7kb in length and composed of an HLS1, HLS2, and 93 HLS3 subtype (O’Bleness et al. 2012). While Olduvai sequences show a human-specific range in 94 copy number, the domains are highly copy number polymorphic among humans, exhibiting a 95 broad normal distribution (Davis et al. 2014). Despite the rapid and extreme nature of the 96 Olduvai triplet expansion in the human species, the genomic factors that drove the process 97 have remained unexplained. Similarly, the genomic mechanism that underlies the extensive 98 Olduvai copy number variation observed within the human population remains unknown. 99 G-quadruplexes (G4s) are non-B form DNA structures characterized by two or more 100 stacked planar guanine tetrads. The characteristic sequence motif of these structures is four or 101 more closely spaced runs of three or more guanines (Bochman et al. 2012). The guanines are 102 stabilized by non-canonical H-bonding in a coplanar arrangement to form G-quartets and a 103 stacked array of G-quartets make up a G4 structure. G4 sequence motifs are over-represented 5 104 in meiotic and mitotic double-stranded breaks and are thought to promote genomic instability 105 (Bochman et al. 2012; Maizels and Gray 2013). Here, we provide evidence supporting the view 106 that a potential G4 motif specific to Olduvai sequences may be behind both their evolutionary 107 hyperamplification and the high degree of variation associated with Olduvai triplets in existing 108 humans. 109 110 Materials and Methods 111 Sequence analysis of predicted breakpoint regions 112 The coordinates of the relevant introns were obtained as described in Astling et al. 113 (Astling et al. 2017). Reference sequence data for the relevant introns were extracted from 114 hg38 utilizing bedtools v2.26.0 (Quinlan and Hall 2010). The sequences were aligned with 115 Clustal Omega (Rice et al. 2000), and the alignments were visualized with Geneious v10.2.3. 116 Analysis of the pG4 sequence in non-human primates 117 Olduvai sequences in non-human primate genomes were located as described in 118 Zimmer and Montgomery (Zimmer and Montgomery 2015).
Recommended publications
  • Evaluation of Potential Biomarkers for Ewing´S Sarcoma As Cargo of Tumor Derived Exosomes
    TECHNISCHE UNIVERSITÄT MÜNCHEN Klinik und Poliklinik für Kinder- und Jugendmedizin Klinikum rechts der Isar Direktor: Univ.-Prof. Dr. St. Burdach Evaluation of potential biomarkers for Ewing´s sarcoma as cargo of tumor derived exosomes Isabella Viktoria Miller Vollständiger Abdruck der von der Fakultät für Medizin der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Medizin genehmigten Dissertation. Vorsitzender: Univ.-Prof. Dr. E. J. Rummeny Prüfer der Dissertation: 1. Univ.-Prof. Dr. St. Burdach 2. Priv.-Doz. Dr. J. M. E. Teichert-von Lüttichau 3. Univ.-Prof. Dr. A. Krackhardt Die Dissertation wurde am 31.10.2014 bei der Technischen Universität München eingereicht und durch die Fakultät für Medizin am 03.02.2016 angenommen. Contents List of Abbreviations 6 Summary 8 1 Introduction 9 1.1 Ewing´s sarcoma . .9 1.1.1 The Ewing family of tumors . .9 1.1.2 RNA based markers for subclinical disease and their limitations . 10 1.2 Exosomes . 11 1.2.1 Biogenesis and classification . 11 1.2.2 Communication pathways . 12 1.2.3 Roles in tumorigenesis . 14 1.2.3.1 Immunosuppression . 15 1.2.3.2 Angiogenesis . 15 1.2.3.3 Modulation of the microenvironment . 15 1.2.3.4 Metastasis . 16 1.2.3.5 Drug resistance . 17 1.2.4 Diagnostic implications as tumor markers . 17 1.3 Research objectives . 24 1.3.1 Aim of the project . 24 1.3.2 Key questions . 24 2 Materials and Methods 25 2.1 Materials . 25 2.1.1 List of Manufacturers . 25 2.1.2 General materials .
    [Show full text]
  • Universidade Estadual De Campinas Instituto De Biologia
    UNIVERSIDADE ESTADUAL DE CAMPINAS INSTITUTO DE BIOLOGIA VERÔNICA APARECIDA MONTEIRO SAIA CEREDA O PROTEOMA DO CORPO CALOSO DA ESQUIZOFRENIA THE PROTEOME OF THE CORPUS CALLOSUM IN SCHIZOPHRENIA CAMPINAS 2016 1 VERÔNICA APARECIDA MONTEIRO SAIA CEREDA O PROTEOMA DO CORPO CALOSO DA ESQUIZOFRENIA THE PROTEOME OF THE CORPUS CALLOSUM IN SCHIZOPHRENIA Dissertação apresentada ao Instituto de Biologia da Universidade Estadual de Campinas como parte dos requisitos exigidos para a obtenção do Título de Mestra em Biologia Funcional e Molecular na área de concentração de Bioquímica. Dissertation presented to the Institute of Biology of the University of Campinas in partial fulfillment of the requirements for the degree of Master in Functional and Molecular Biology, in the area of Biochemistry. ESTE ARQUIVO DIGITAL CORRESPONDE À VERSÃO FINAL DA DISSERTAÇÃO DEFENDIDA PELA ALUNA VERÔNICA APARECIDA MONTEIRO SAIA CEREDA E ORIENTADA PELO DANIEL MARTINS-DE-SOUZA. Orientador: Daniel Martins-de-Souza CAMPINAS 2016 2 Agência(s) de fomento e nº(s) de processo(s): CNPq, 151787/2F2014-0 Ficha catalográfica Universidade Estadual de Campinas Biblioteca do Instituto de Biologia Mara Janaina de Oliveira - CRB 8/6972 Saia-Cereda, Verônica Aparecida Monteiro, 1988- Sa21p O proteoma do corpo caloso da esquizofrenia / Verônica Aparecida Monteiro Saia Cereda. – Campinas, SP : [s.n.], 2016. Orientador: Daniel Martins de Souza. Dissertação (mestrado) – Universidade Estadual de Campinas, Instituto de Biologia. 1. Esquizofrenia. 2. Espectrometria de massas. 3. Corpo caloso.
    [Show full text]
  • Analysis of Mutational Landscape of Patients with Chronic Lymphocytic Leukemia
    Analysis of mutational landscape of patients with chronic lymphocytic leukemia A.V. Terskikh1, A.A. Samsonova2, A.A. Kanapin2 1-Peter the Great St.Petersburg Polytechnic University, St. Petersburg, Russia, anastasiya- [email protected]; 2-Department of Oncology, University of Oxford, Oxford, UK, [email protected], [email protected] A precise understanding of the genomic features of chronic lymphocytic leukemia (CLL) may benefit the study of the disease’s staging and treatment. Genomic landscape of CLL probably reflects either an unknown underlying biochemical mechanism playing a key role in CLL or multiple biochemical pathways independently driving the development of this tumor. The elucidation of either scenario may have important consequences on the clinical management of CLL. Our aim is to analyze mutational landscape of the disease to identify potential pathways driving the pathology. Chronic lymphocytic leukemia is a clonal neoplasia of B-lymphocytes which accumulate mainly in the blood, bone marrow, lymph nodes and spleen [1]. Notably, these B- lymphocytes are differentiated, and can remain in an arrested state for several years after diagnosis. Two major molecular subtypes can be distinguished, characterized respectively by a high or low number of somatic hypermutations in the variable region of immunoglobulin genes [2]. This classification system was improved with the characterization of additional genomic and transcriptomic factors [3]. However, the genomic events that dictate the initiation and heterogeneous evolution of CLL remained partially unknown. Next-Generation Sequencing (NGS) allows the comparison of the genome of tumor cells with the constitutive genome in normal tissues of the same patients. The variants present in the tumor genome and absent from the germinal genome are called somatic mutations, and constitute a requisite of cancer development.
    [Show full text]
  • Downregulation of Nuclear and Cytoplasmic Chibby Is Associated with Advanced Cervical Cancer
    6632 ONCOLOGY LETTERS 14: 6632-6644, 2017 Downregulation of nuclear and cytoplasmic Chibby is associated with advanced cervical cancer MING-CHANG YANG1,2*, SHANG-TAO CHIEN3,4*, TZU-FENG YANG2,5, SHIH-YI LIN3, TAI-MIN LEE3 and YI-REN HONG1,6,7 1 2 Department of Biological Sciences, National Sun Yat-sen University, Kaohsiung 80424; Laboratory of 3 Medical Research; Department of Pathology, Kaohsiung Armed Forces General Hospital, Kaohsiung 80284; 4Department of Medical Laboratory Sciences and Biotechnology, Fooyin University, Kaohsiung 83102; 5Department of Psychiatry, Kaohsiung Armed Forces General Hospital, Kaohsiung 80284; 6Department of Biochemistry, Faculty of Medicine, College of Medicine; 7Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan, R.O.C. Received March 11, 2014; Accepted June 9, 2017 DOI: 10.3892/ol.2017.7050 Abstract. Chibby has been identified as a putative tumor tumors, in which a significantly increased level of protein suppressor and antagonist to β-catenin, thereby controlling expression was detected. Chibby may be a tumor suppressor in the Wnt signaling pathway. Chibby is typically downregulated cervical cancer, since the dysregulation of Chibby expression is in numerous types of cancer and may be associated with associated with tumorigenesis in cervical cancer. Chibby and tumorigenesis. The present study aimed at clarifying the β-catenin expression together may potentially to a biomarker following: i) Whether Chibby antagonizes β-catenin in cervical for disease progression in cervical cancer. cancer; ii) whether Chibby and β-catenin mRNA expression is associated with cancer progression; and iii) whether Chibby Introduction and β-catenin expression may be used as a biomarker.
    [Show full text]
  • Novel Genetic Features of Human and Mouse Purkinje Cell Differentiation Defined by Comparative Transcriptomics
    Novel genetic features of human and mouse Purkinje cell differentiation defined by comparative transcriptomics David E. Buchholza, Thomas S. Carrollb, Arif Kocabasa, Xiaodong Zhua, Hourinaz Behestia, Phyllis L. Faustc, Lauren Stalbowa, Yin Fanga, and Mary E. Hattena,1 aLaboratory of Developmental Neurobiology, The Rockefeller University, New York, NY 10065; bBioinformatics Resource Center, The Rockefeller University, New York, NY 10065; and cDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center and the New York Presbyterian Hospital, New York, NY 10032 Contributed by Mary E. Hatten, April 22, 2020 (sent for review January 3, 2020; reviewed by Lorenz Studer and Hynek Wichterle) Comparative transcriptomics between differentiating human plu- is ataxia-telangiectasia, which shows massive loss of PCs in hu- ripotent stem cells (hPSCs) and developing mouse neurons offers a mans but not in the mouse (11). Human pluripotent stem cells powerful approach to compare genetic and epigenetic pathways (hPSCs) provide a complementary approach to studying human in human and mouse neurons. To analyze human Purkinje cell disease in the mouse (12–14). Validated methods to derive (PC) differentiation, we optimized a protocol to generate human specific neural subtypes from hPSCs are necessary prerequisites pluripotent stem cell-derived Purkinje cells (hPSC-PCs) that formed to disease modeling. We and others have recently developed synapses when cultured with mouse cerebellar glia and granule protocols to derive PCs from hPSCs (15–18). cells and fired large calcium currents, measured with the geneti- One limitation of most hPSC-derived central nervous system cally encoded calcium indicator jRGECO1a. To directly compare (CNS) neurons is the lack of genetic information, especially of global gene expression of hPSC-PCs with developing mouse PCs, transcriptomic signatures, to rigorously identify specific types of we used translating ribosomal affinity purification (TRAP).
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis
    Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis Deepti Verma, Anna-Karin Ekman, Cecilia Bivik Eding and Charlotta Enerbäck The self-archived postprint version of this journal article is available at Linköping University Institutional Repository (DiVA): http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-147791 N.B.: When citing this work, cite the original publication. Verma, D., Ekman, A., Bivik Eding, C., Enerbäck, C., (2018), Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis, Journal of Investigative Dermatology, 138(5), 1088-1093. https://doi.org/10.1016/j.jid.2017.11.036 Original publication available at: https://doi.org/10.1016/j.jid.2017.11.036 Copyright: Elsevier http://www.elsevier.com/ Genome-Wide DNA Methylation Profiling Identifies Differential Methylation in Uninvolved Psoriatic Epidermis Deepti Verma*a, Anna-Karin Ekman*a, Cecilia Bivik Edinga and Charlotta Enerbäcka *Authors contributed equally aIngrid Asp Psoriasis Research Center, Department of Clinical and Experimental Medicine, Division of Dermatology, Linköping University, Linköping, Sweden Corresponding author: Charlotta Enerbäck Ingrid Asp Psoriasis Research Center, Department of Clinical and Experimental Medicine, Linköping University SE-581 85 Linköping, Sweden Phone: +46 10 103 7429 E-mail: [email protected] Short title Differential methylation in psoriasis Abbreviations CGI, CpG island; DMS, differentially methylated site; RRBS, reduced representation bisulphite sequencing Keywords (max 6) psoriasis, epidermis, methylation, Wnt, susceptibility, expression 1 ABSTRACT Psoriasis is a chronic inflammatory skin disease with both local and systemic components. Genome-wide approaches have identified more than 60 psoriasis-susceptibility loci, but genes are estimated to explain only one third of the heritability in psoriasis, suggesting additional, yet unidentified, sources of heritability.
    [Show full text]
  • BIOTECHNO 2020 Proceedings
    BIOTECHNO 2020 The Twelfth International Conference on Bioinformatics, Biocomputational Systems and Biotechnologies ISBN: 978-1-61208-792-4 September 27th – October 1st, 2020 BIOTECHNO 2020 Editors Birgit Gersbeck-Schierholz, Leibniz Universität Hannover, Germany 1 / 34 BIOTECHNO 2020 Forward The Twelfth International Conference on Bioinformatics, Biocomputational Systems and Biotechnologies (BIOTECHNO 2020) continued a series of events covering these three main areas: bioinformatics, biomedical technologies, and biocomputing. Bioinformatics deals with the system-level study of complex interactions in biosystems providing a quantitative systemic approach to understand them and appropriate tool support and concepts to model them. Understanding and modeling biosystems requires simulation of biological behaviors and functions. Bioinformatics itself constitutes a vast area of research and specialization, as many classical domains such as databases, modeling, and regular expressions are used to represent, store, retrieve and process a huge volume of knowledge. Biotechnology is defined as the industrial use of living organisms or biological techniques developed through basic research. Bio-oriented technologies became very popular in various research topics and industrial market segments. Current human mechanisms seem to offer significant ways for improving theories, algorithms, technologies, products and systems. The focus is driven by fundamentals in approaching and applying biotechnologies in terms of engineering methods, special electronics, and special materials and systems. Borrowing simplicity and performance from the real life, biodevices cover a large spectrum of areas, from sensors, chips, and biometry to computing. One of the chief domains is represented by the biomedical biotechnologies, from instrumentation to monitoring, from simple sensors to integrated systems, including image processing and visualization systems. As the state-of-the- art evolves at fast speed, new biotechnologies and biosystems become available.
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • In a Neuroblastoma Patient Disrupts NBPF1, a Novel Putative Tumor
    A Constitutional Translocation t(1;17)(p36.2;q11.2) in a Neuroblastoma Patient Disrupts NBPF1 , a novel putative tumor suppressor gene Vanessa Andries , Karl Vandepoele , Katrien Staes, and Frans van Roy Molecular Cell Biology Unit, Dept. for Molecular Biomedical Research, VIB/Ghent University, Technologiepark 927, B-9052 Ghent (Zwijnaarde) E-mail: [email protected], [email protected] Neuroblastoma (NB) is the most common extracranial solid tumor in children and is characterized by a number of recurrent genetic alterations: gain of chromosome 17q, amplification of MYCN , and deletion of 1p36. We found that a constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient (Laureys et al., 1995) resulted in the disruption of a novel gene, NBPF1 (Neuroblastoma Breakpoint Family, member 1). This gene is built of repetitive elements and is subject of structural variation in the human population. Thorough analysis of genomic sequences revealed that NBPF1 is a member of a recently expanded gene family, with gene copies located on segmental duplications of chromosome 1 (Vandepoele et al., 2005). Both in silico and in vitro analysis failed to identify any rodent orthologs for the human NBPF genes. The members of the NBPF gene family are widely expressed, both in normal and cancerous tissues, including neuroblastoma cells. Our identification of NBPF-interacting proteins may link these genes to important signalling pathways such as the Wnt and NF-kappaB signalling pathways. The high sequence identity between different NBPF paralogs has thus far disabled the analysis of gene-specific expression patterns, but the development of an NBPF1 -specific qRT-PCR assay is in progress.
    [Show full text]
  • ATA33632-NBPF3 Rabbit Polyclonal Antibody
    ATAGENIX LABORATORIES Catalog Number:ATA33632 NBPF3 rabbit Polyclonal Antibody Product overview product name NBPF3 rabbit Polyclonal Antibody catalog No. ATA33632 Category Primary antibodies Host Rabbit Species specificity Human Tested applications WB,ELISA Clonality Polyclonal Conjugation Unconjugated Immunogen Synthesized peptide derived from human protein . at AA range: 410-490 Product performance Form Liquid Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 °C for frequent use. Store at -20 to -80 °C for twelve months from the date of receipt. Purity The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. Dilution range WB 1:500-2000 ELISA 1:5000-20000 Product background neuroblastoma breakpoint family member 3(NBPF3) Homo sapiens This gene is a member of the neuroblastoma breakpoint family (NBPF) which consists of dozens of recently duplicated genes primarily located in segmental duplications on human chromosome 1. This gene family has experienced its greatest expansion within the human lineage and has expanded, to a lesser extent, among primates in general. Members of this gene family are characterized by tandemly repeated copies of DUF1220 protein domains. DUF1220 copy number variations in human chromosomal region 1q21.1, where most DUF1220 domains are located, have been implicated in a number of developmental and neurogenetic diseases such as microcephaly, macrocephaly, autism, schizophrenia, mental retardation, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies. Altered expression of some gene family members is associated with several types of cancer. This gene fami Web:www.atagenix.com E-mail: [email protected] Tel: 027-87433958.
    [Show full text]
  • Analysis of the Indacaterol-Regulated Transcriptome in Human Airway
    Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2018/04/13/jpet.118.249292.DC1 1521-0103/366/1/220–236$35.00 https://doi.org/10.1124/jpet.118.249292 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 366:220–236, July 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the s Adverse and Therapeutic Effects of b2-Adrenoceptor Agonists Dong Yan, Omar Hamed, Taruna Joshi,1 Mahmoud M. Mostafa, Kyla C. Jamieson, Radhika Joshi, Robert Newton, and Mark A. Giembycz Departments of Physiology and Pharmacology (D.Y., O.H., T.J., K.C.J., R.J., M.A.G.) and Cell Biology and Anatomy (M.M.M., R.N.), Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Received March 22, 2018; accepted April 11, 2018 Downloaded from ABSTRACT The contribution of gene expression changes to the adverse and activity, and positive regulation of neutrophil chemotaxis. The therapeutic effects of b2-adrenoceptor agonists in asthma was general enriched GO term extracellular space was also associ- investigated using human airway epithelial cells as a therapeu- ated with indacaterol-induced genes, and many of those, in- tically relevant target. Operational model-fitting established that cluding CRISPLD2, DMBT1, GAS1, and SOCS3, have putative jpet.aspetjournals.org the long-acting b2-adrenoceptor agonists (LABA) indacaterol, anti-inflammatory, antibacterial, and/or antiviral activity. Numer- salmeterol, formoterol, and picumeterol were full agonists on ous indacaterol-regulated genes were also induced or repressed BEAS-2B cells transfected with a cAMP-response element in BEAS-2B cells and human primary bronchial epithelial cells by reporter but differed in efficacy (indacaterol $ formoterol .
    [Show full text]